Summary
Endothelium-derived hyperpolarizing factor is defined as that substance which produces vascular smooth muscle hyperpolarization which cannot be explained by nitric oxide or by a cyclo-oxygenase product such as prostacyclin. The possibility that the factor is an epoxyeicosatrienoic acid or a cannabinoid agonist such as anandamide continues to be investigated, but definitive evidence in favour of either is lacking. The sensitivity of EDHF-mediated responses to charybdotoxin, to apamin or to mixtures of these two toxins may indicate the opening of more than one smooth muscle K-chan-nel, but the possibility that these are located on the vascular endothelium is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
H. Kuriyama and H. Suzuki: Br. J. Pharmacol. 64, 493–501 (1978).
K. Kitamura and H. Kuriyama: J. Physiol. 293, 119–133 (1979).
R.F. Furchgott and J.V. Zawadzki: Nature 288, 373–376 (1980).
T.B. Bolton, RJ. Lang and T. Takewaki: J. Physiol. 351, 549–572 (1984).
R.R Furchgott: Acta Physiol. Scand. 139, 257–270 (1990).
S.G. Taylor, J.S. Southerton, A.H. Weston and J.R. Baker: Br. J. Pharmacol. 94, 853–863 (1988).
A.H. Weston, S.G. Taylor, J.S. Southerton, K.M. Bray, D.T. Newgreen and A.D. McHarg, in: J.A. Bevan, H. Majewski, R.A. Maxwell and D.R Story (eds.): Vascular Neuroeffector Mechanisms, Vol 10, IRL Press, Oxford 1988, pp. 193–200.
S.G. Taylor and A.H. Weston: Trends Pharmacol. Sci. 9, 272–274 (1988).
CJ. Garland, R Plane, B.K. Kemp and T.M. Cocks: Trends Pharmacol. Sci. 16, 23–30 (1995).
D.S. Bredt and S.H. Snyder: Ann. Rev. Biochem. 63, 175–195 (1994).
T. Itoh, Y. Kanmura, H. Kuriyama and T. Sasaguri: Br. J. Pharmacol. 84, 393–406 (1985).
M. Vrolix, L. Raeymaekers, F. Wuytack, F. Hofmann and R. Casteels: Biochem. J. 255, 855–863 (1988).
G. Siegel, G. Stock, R Schnalke and B. Litza, in: RJ. Gryglewski and G. Stock (eds.): Prostacyclin and Its Stable Analogue Iloprost, Springer-Verlag, Berlin 1987, pp. 143–149.
M. Tare, H.C. Parkington, H.A. Coleman, T.O. Neild and GJ. Dusting: Nature 346, 69–71 (1990).
H.C. Parkington, M. Tare, M.A. Tonta and H.A Coleman: J. Physiol. 465, 459–476 (1993).
H.C. Parkington, M.A. Tonta, H.A. Coleman and M. Tare: J. Physiol. 484, 469–480 (1995).
M.E. Murphy and J.E. Brayden: J. Physiol. 486, 47–58 (1995).
B. Robertson and D.G. Owen: Br. J. Pharmacol. 109, 725–735 (1993).
M. Kubo, Y. Nakaya, S. Matsuoka, K. Saito and Y. Kuroda: Circ. Res. 74, 471–476 (1994).
V.M. Bolotina, S. Najibi, JJ. Palacino, PJ. Pagano and R.A. Cohen: Nature 368, 850–853 (1994).
S.L. Archer, J.M.C. Huang, H.L. Reeve, V. Hampl, S. Tolarova, E. Michelakis and E.K. Weir: Circ. Res. 78, 431–442 (1996).
P.M. Zygmunt, T. Ryman and E.D. Högestätt: Acta Physiol. Scand. 155, 257–266 (1995).
R.A. Cohen, F. Plane, S. Najibi, I. Huk, T. Malinski and CJ. Garland: Proc. Natl. Acad. Sci. USA 94, 4193–4198 (1997).
M.E. Murphy and J.E. Brayden: J. Physiol. 489, 723–734 (1995).
G. Chen, H. Suzuki and A.H. Weston: Br. J. Pharmacol. 95, 1165–1174 (1988).
A.H. Huang, R. Busse and E. Bassenge: Naunyn Schmiedeberg’s Arch. Pharmacol. 338, 438–442 (1988).
E. Nishiye, K. Nakao, T. Itoh and H. Kuriyama: Br. J. Pharmacol. 96, 645–655 (1989).
CJ. Garland and G.A. McPherson: Br. J. Pharmacol. 105, 429–435 (1992).
E.V. Kilpatrick and T.M. Cocks: Br. J. Pharmacol. 112, 557–565 (1994).
A.I. McCulloch, F.E. Bottrill, M.D. Randall and C.R. Hiley: Br. J. Pharmacol. 120, 1431–1438 (1997).
M. Félétou and P.M. Vanhoutte: Br. J. Pharmacol. 93, 515–524 (1988).
G.F. Chen and H. Suzuki: Am. J. Physiol. 260, H1037–H1042 (1991).
F. Plane, T. Pearson and CJ. Garland: Br. J. Pharmacol. 115, 31–38 (1995).
M. Hecker, A. Mülsch, E. Bassenge and R. Busse: Am. J. Physiol. 265, H828–H833 (1993).
J.V. Mombouli, I. Bissiriou, V.D. Agboton and P.M. Vanhoutte: Biochem. Biophys. Res. Commun. 221, 484–488 (1996).
J.L. Bény: Eur. J. Pharmacol. 185, 235–238 (1990).
L. Missiaen, H. De Smed, J.B. Parys, I. Sienaert, S. Valingen and R. Casteels: J. Biol. Chem. 271, 12287–12293 (1996).
K. Fujii, M. Tominaga, S. Ohmori, K. Kobayashi, T. Koga, Y. Takata and M. Fujishima: Circ. Res. 70, 660–669 (1992).
G.A. McPherson and J.A. Angus: Br. J. Pharmacol. 103, 1184–1190 (1991).
H. Hashitani and H. Suzuki: J. Physiol. 501, 319–329 (1997).
P.M. Zygmunt, K. Waldeck and E.D. Högestätt: Acta Physiol. Scand. 152, 375–384 (1994).
J. Petersson, P.M. Zygmunt and E.D. Högestätt: Br. J. Pharmacol. 120,1344–1350 (1997).
C.L. Cowan, J J. Palacino, S. Najibi and R.A. Cohen: J. Pharmacol. Exp. Ther. 266, 1482–1489 (1993).
D. Fulton, J.C. McGiff and J. Quilley: Br. J. Pharmacol. 113, 954–958 (1994).
V. Lischke, R. Busse and M. Hecker: Br. J. Pharmacol. 115, 969–974 (1995a).
K.G. Chandy and G.A. Gutman, in: R. A. North (ed.): Ligand and Voltage-Gated Ion Channels, CRC Press, London 1995, pp. 1–71.
P.M. Zygmunt and E.D. Högestätt: Br. J. Pharmacol. 117, 1600–1606 (1996).
M.L. Garcia, M. Hanner, H.G. Knaus, R. Koch, W. Schmalhofer, R.S. Slaughter and GJ. Kaczorowski: Advances in Pharmacology, 39, 425–471 (1997).
R. Popp, J. Bauersachs, M. Hecker, I. Fleming and R. Busse: J. Physiol. 497, 699–709 (1996).
J. Daut: J. Physiol. 502, 469 (1997).
P.M. Zygmunt, G. Edwards, A.H. Weston, B. Larsson and E.D. Högestätt: Br. J. Pharmacol. 121, 141–149 (1997).
A.S. Adeagbo and C.R. Triggle: J. Cardiovasc. Pharmacol. 21, 423–429 (1993).
M. Hecker, A.T. Bara, J. Bauersachs and R. Busse: J. Physiol. 481, 407–414 (1994).
A. Garcia-Pascual, A. Labadia, E. Jimenez and G. Costa: Br. J. Pharmacol. 115, 1221–1230 (1995).
N. Yamakawa, M. Ohhashi, S. Waga and T. Itoh: Br. J. Pharmacol. 121, 1315–1322 (1997).
F. Vogalis and R.K. Goyal: J. Physiol. 502, 497–508 (1997).
C. Van Renterghem and M. Lazdunski: Pflugers Arch. 420, 417–423 (1992).
S.M. Marchenko and S.O. Sage: J. Physiol. 492, 53–60 (1996).
K. Muraki, Y. Imaizumi, S. Ohya, K. Sato, T. Takii, K. Onozaki and M. Watanabe: Biochem. Biophys. Res. Commun. 236, 340–343 (1997).
GJ. Waldron and CJ. Garland: Can. J. Physiol. Pharmacol. 72 (suppl. 1), 115 (1994).
C. Corriu, M. Félétou, E. Canet and P.M. Vanhoutte: Br. J. Pharmacol. 119, 959–964 (1996).
W.B. Campbell, D. Gebremedhin, P.E Pratt PF and D.R. Harder: Circ. Res. 78, 415–423 (1996).
G.E Chen and D.W. Cheung: Circ. Res. 79, 827–833 (1996).
G.E. Revtyak, A.R. Johnson and W.B. Campbell: Am. J. Physiol. 254, C8–C19 (1988).
K.A. Pritchard Jr, R.R. Tota, M.B. Stemerman and P.Y. Wong: Biochem. Biophys. Res. Commun. 167, 137–142 (1990).
M. Rosolowsky, J.R. Falck and W.B. Campbell: Adv. Prostaglandin Thromb. Res. 21, 213–216 (1990).
M. Rosolowsky and W.B. Campbell: Biochim. Biophys. Acta 1299, 267–277 (1996).
D. Gebremedhin, Y.-H. Ma, J.R. Falck, RJ. Roman, M. Van Rollins and D.R. Harder: Am. J. Physiol. 263, H519–H525 (1992).
P.L. Li, A.P. Zou and W.B. Campbell: Hypertension 29, 262–267 (1997).
J.C. McGiff: Annu. Rev. Pharmacol. Toxicol. 31, 339–369 (1991).
W.F. Graier, S. Simecek and M. Sturek: J. Physiol. 482, 259–274 (1995).
B.G. Hoebel, G.M. Kostner and W.F. Graier: Br. J. Pharmacol. 121, 1579–1588 (1997).
P.L. Li and W.B. Campbell: Circ. Res. 80, 877–884 (1997).
K.G. Proctor, J.R. Falck and A.J. Capdevila: Circ. Res. 60, 50–59 (1987).
P.M. Zygmunt, G. Edwards, A.H. Weston, S.C. Davis and E.D. Högestätt: Br. J. Pharmacol. 118, 1147–1152 (1996).
M.D. Randall, S.P.H. Alexander, T. Bennett, E.A. Boyd, J.R. Fry, S.M. Gardiner, P.A. Kemp, A.I. McCulloch and D.A. Kendall: Biochem. Biophys. Res. Commun. 229, 114–120 (1996).
W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger and R. Mechoulam: Science 258, 1946–1949 (1992).
S. Munro, K.L. Thomas and M. Abu-Shaar: Nature 365, 61–65 (1993).
R.G. Pertwee: Pharmacol. Ther. 74, 129–180 (1997).
EJ. Ishac, L. Jiang, K.D. Lake, K. Varga, M.E. Aboo and G. Kunos: Br. J. Pharmacol. 118, 2023–2028 (1996).
R.G. Pertwee and S.R. Fernando: Br. J. Pharmacol. 118, 2053–2058 (1996).
V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz and D. Piomelli: Nature 372, 686–691 (1994).
F. Plane, M. Holland, GJ. Waldron, CJ. Garland and J.P. Boyle: Br. J. Pharmacol. 121, 1509–1511 (1997).
R. White and C.R. Hiley: Br. J. Pharmacol. 122, 1573–1584 (1997).
M. Rinaldi-Carmona, F. Barth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J. C. Brelière, G. Le Fur: FEBS Lett. 350, 240–244 (1994).
V. M. Showalter, D. R. Compton, B. R. Martin and M. E. Abood: J. Pharmacol. Exp. Ther. 278, 989–999 (1996).
T. Chataigneau, C. Thollon, J.-P. Iliou, M. Félétou, J.-P. Vilaine, J. Duhault and P.M. Vanhoutte: J. Vasc. Res. 34 (Suppl. 1), 10 (1997).
P.M. Zygmunt, E.D. Högestätt, K. Waldeck, G. Edwards, AJ. Kirkup and A.H. Weston: Br. J. Pharmacol. 122, 1679–1686 (1997).
W. R. Kukovetz, W. F. Graier and K. Groschner: Jpn. J. Pharmacol. 58, 213P–219P (1992).
K. Groschner, W. F. Graier and W. R. Kukovetz: Biochim. Biophys. Acta 1137, 162–170 (1992).
K. Groschner, W. F. Graier and W. R. Kukovetz: Circ. Res. 75, 304–314 (1994).
A. Lückhoff and R. Busse: Naunyn Schmiedeberg’s Arch. Pharmacol. 342, 94–99 (1990).
P.C. Brunet and J.L. Bény: Blood Vessels 26, 228–234 (1989).
T.L. Little, J. Xia and B.R. Duling: Circ. Res. 76, 498–504 (1995).
J.L. Bény and F. Chabaud, in: P. M. Vanhoutte (ed.): Endothelium-Derived Hyperpolarizing Factor, Harwood Academic Publishers GmbH, Amsterdam 1996, pp.41–49.
E. Kühberger, K. Groschner, W.R. Kukovetz and F. Brunner: Br. J. Pharmacol. 113, 1289–1294 (1994).
G. Schmilinsky-Fluri, V. Valiunas, M. Willi, R. Weingart: J. Mol. Cell. Cardiol. 29, 1703–1713 (1997).
A.G. Knapp and J.E. Dowling: Nature 325, 437–439 (1987).
S.H. DeVries and E. A. Schwartz: J. Physiol. 414, 351–375 (1989).
E. Miyachi, M. Murakami and T. Nakaki: NeuroReport 1, 107–110 (1990).
C.B. Lu and D.G. McMahon DG: J. Physiol. 499, 689–699 (1997).
J. Bauersachs, R. Popp, M. Hecker, E. Sauer, I. Fleming and R. Busse: Circulation 94, 3341–3347 (1996).
J.L. Bény: Pflugers Arch. 433, 364–367 (1997).
J.L. Bény and C. Pacicca: Am. J. Physiol. 266, H1465–1472 (1994).
G. Chen, H. Hashitani and H. Suzuki: Br. J. Pharmacol. 98, 950–956 (1989).
K. Bray and U. Quast: Br. J. Pharmacol. 102, 585–594 (1991).
FJ. Haddy: Clin. Invest. Med. 10, 547–554 (1987).
J.G. McCarron and W. Halpern: Am. J. Physiol. 259, H902–H908 (1990).
H.M. Prior, N. Webster, K. Quinn, DJ. Beech and M.S. Yates: Cardiovasc. Res., in press 1998.
P.M. Zygmunt: PhD Thesis, Lund University, Sweden 1995.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Basel AG
About this chapter
Cite this chapter
Edwards, G., Weston, A.H. (1998). Endothelium-derived hyperpolarizing factor — a critical appraisal. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 50. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8833-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8833-2_2
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9792-1
Online ISBN: 978-3-0348-8833-2
eBook Packages: Springer Book Archive